An Update on Sphingosine-1-phosphate and Other Sphingolipid Mediators

Overview

Journal Nat Chem Biol

Specialties Biochemistry
Biology
Chemistry

Date 2010 Jun 19

PMID 20559316

Citations 166

Authors

Henrik Fyrst

Julie D Saba

Affiliations

Soon will be listed here.

Abstract

Sphingolipids comprise a complex family of naturally occurring molecules that are enriched in lipid rafts and contribute to their unique biochemical properties. Membrane sphingolipids also serve as a reservoir for bioactive metabolites including sphingosine, ceramide, sphingosine-1-phosphate and ceramide-1-phosphate. Among these, sphingosine-1-phosphate has emerged as a central regulator of mammalian biology. Sphingosine-1-phosphate is essential for mammalian brain and cardiac development and for maturation of the systemic circulatory system and lymphatics. In addition, sphingosine-1-phosphate contributes to trafficking and effector functions of lymphocytes and other hematopoietic cells and protects against various forms of tissue injury. However, sphingosine-1-phosphate is also an oncogenic lipid that promotes tumor growth and progression. Recent preclinical and clinical investigations using pharmacological agents that target sphingosine-1-phosphate, its receptors and the enzymes required for its biosynthesis and degradation demonstrate the promise and potential risks of modulating sphingosine-1-phosphate signaling in treatment strategies for autoimmunity, cancer, cardiovascular disease and other pathological conditions.

Citing Articles

Intrathymic Cell Migration: Implications in Thymocyte Development and T Lymphocyte Repertoire Formation.

Mendes-da-Cruz D, Lemos J, Belorio E, Savino W Adv Exp Med Biol. 2025; 1471:139-175.

PMID: 40067586 DOI: 10.1007/978-3-031-77921-3_5.

ApoM maintains cellular homeostasis between mitophagy and apoptosis by affecting the stability of Nnt mRNA through the Zic3-ApoM-Elavl2-Nnt axis during neural tube closure.

Liu Q, Liu D, Wang Y, Wei X, Ma W, Gu H Cell Death Dis. 2025; 16(1):29.

PMID: 39827160 PMC: 11742887. DOI: 10.1038/s41419-025-07343-3.

Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication.

McKenna S, Jung K, Wolf J, Seo Y, Hahm B Virology. 2025; 603:110367.

PMID: 39754863 PMC: 11793951. DOI: 10.1016/j.virol.2024.110367.

Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases.

Fu F, Li W, Zheng X, Wu Y, Du D, Han C Int J Mol Sci. 2024; 25(21).

PMID: 39519028 PMC: 11545938. DOI: 10.3390/ijms252111474.

Migrasomes: Biogenesis, physiological roles, and therapeutic potentials.

Jiao H, Yu L J Cell Biol. 2024; 223(11).

PMID: 39400310 PMC: 11473597. DOI: 10.1083/jcb.202403051.

References

Stratford S, Hoehn K, Liu F, Summers S . Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem. 2004; 279(35):36608-15. DOI: 10.1074/jbc.M406499200. View

Cohen J, Barkhof F, Comi G, Hartung H, Khatri B, Montalban X . Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med. 2010; 362(5):402-15. DOI: 10.1056/NEJMoa0907839. View

Weigert A, Cremer S, Schmidt M, von Knethen A, Angioni C, Geisslinger G . Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. Blood. 2010; 115(17):3531-40. DOI: 10.1182/blood-2009-10-243444. View

Serra M, Saba J . Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. Adv Enzyme Regul. 2009; 50(1):349-62. PMC: 2862839. DOI: 10.1016/j.advenzreg.2009.10.024. View

Xia P, Gamble J, Wang L, Pitson S, Moretti P, Wattenberg B . An oncogenic role of sphingosine kinase. Curr Biol. 2000; 10(23):1527-30. DOI: 10.1016/s0960-9822(00)00834-4. View

Morita Y, Perez G, Paris F, Miranda S, Ehleiter D, Haimovitz-Friedman A . Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med. 2000; 6(10):1109-14. DOI: 10.1038/80442. View

Lahiri S, Futerman A . The metabolism and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci. 2007; 64(17):2270-84. PMC: 11136246. DOI: 10.1007/s00018-007-7076-0. View

Jarman K, Moretti P, Zebol J, Pitson S . Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1. J Biol Chem. 2009; 285(1):483-92. PMC: 2804196. DOI: 10.1074/jbc.M109.068395. View

Mizugishi K, Li C, Olivera A, Bielawski J, Bielawska A, Deng C . Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice. J Clin Invest. 2007; 117(10):2993-3006. PMC: 1978422. DOI: 10.1172/JCI30674. View

10.

Chalfant C, Spiegel S . Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci. 2005; 118(Pt 20):4605-12. DOI: 10.1242/jcs.02637. View

11.

Mukhopadhyay D, Howell K, Riezman H, Capitani G . Identifying key residues of sphinganine-1-phosphate lyase for function in vivo and in vitro. J Biol Chem. 2008; 283(29):20159-69. DOI: 10.1074/jbc.M709753200. View

12.

Allende M, Tuymetova G, Lee B, Bonifacino E, Wu Y, Proia R . S1P1 receptor directs the release of immature B cells from bone marrow into blood. J Exp Med. 2010; 207(5):1113-24. PMC: 2867276. DOI: 10.1084/jem.20092210. View

13.

Miron V, Ludwin S, Darlington P, Jarjour A, Soliven B, Kennedy T . Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. Am J Pathol. 2010; 176(6):2682-94. PMC: 2877831. DOI: 10.2353/ajpath.2010.091234. View

14.

Visentin B, Vekich J, Sibbald B, Cavalli A, Moreno K, Matteo R . Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell. 2006; 9(3):225-38. DOI: 10.1016/j.ccr.2006.02.023. View

15.

Symolon H, Schmelz E, Dillehay D, Merrill Jr A . Dietary soy sphingolipids suppress tumorigenesis and gene expression in 1,2-dimethylhydrazine-treated CF1 mice and ApcMin/+ mice. J Nutr. 2004; 134(5):1157-61. DOI: 10.1093/jn/134.5.1157. View

16.

Bai A, Hu H, Yeung M, Chen J . Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J Immunol. 2007; 178(12):7632-9. DOI: 10.4049/jimmunol.178.12.7632. View

17.

Levi M, Meijler M, Gomez-Munoz A, Zor T . Distinct receptor-mediated activities in macrophages for natural ceramide-1-phosphate (C1P) and for phospho-ceramide analogue-1 (PCERA-1). Mol Cell Endocrinol. 2009; 314(2):248-55. DOI: 10.1016/j.mce.2009.05.007. View

18.

Samy E, Meyer C, Caplazi P, Langrish C, Lora J, Bluethmann H . Cutting edge: Modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphate. J Immunol. 2007; 179(9):5644-8. DOI: 10.4049/jimmunol.179.9.5644. View

19.

Means C, Xiao C, Li Z, Zhang T, Omens J, Ishii I . Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2007; 292(6):H2944-51. DOI: 10.1152/ajpheart.01331.2006. View

20.

Skoura A, Hla T . Lysophospholipid receptors in vertebrate development, physiology, and pathology. J Lipid Res. 2008; 50 Suppl:S293-8. PMC: 2674736. DOI: 10.1194/jlr.R800047-JLR200. View